Back to results
US 10,588,900 B2Granted
Quinolinone lysyl oxidase-like 2 inhibitors and uses thereof
AssigneePharmakea, Inc.
InventorsMartin W. Rowbottom, John Howard Hutchinson
Life of this patent
Estimating the term…
Abstract
Described herein are compounds that are LOXL2 inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with LOXL2 activity.
Claims20
A compound that has the structure of Formula (I), or a pharmaceutically acceptable salt, or solvate thereof:
- wherein,
- each R1 is independently H, D, or F;
- R2 is Br, —CN, —OH, —OC2-C6alkyl, —OC1-C6fluoroalkyl, —SR5, —S(═O)R4, —S(═O)2R4, —S(═O)2N(R5)2, —NR5S(═O)2R4, —C(═O)R4, —OC(═O)R4, —CO2R5, —OCO2R4, —N(R5)2, —OC(═O)N(R5)2, —C(═O)N(R5)2, —NR5C(═O)R4, —NR5C(═O)OR4, C1-C6fluoroalkyl, C1-C6deuteroalkyl, —OC1-C6deuteroalkyl, substituted or unsubstituted C1-C6heteroalkyl, substituted or unsubstituted C2-C6alkenyl, or substituted or unsubstituted C2-C6alkynyl;
- or R2 is A-L1-;
- L1 is absent, —O—, —NR5—, —S—, —S═O—, —S(═O)2—, C1-C6alkylene, —O(C1-C6alkylene)-, —NR5(C1-C6alkylene)-, —S(C1-C6alkylene)-, —S═O(C1-C6alkylene)-, or —S(═O)2C1-C6alkylene-;
- A is a cyclic ring that is a substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted C3-C10cycloalkyl, substituted or unsubstituted C3-C10cycloalkenyl, or substituted or unsubstituted C2-C10heterocycloalkyl, wherein if A is substituted then A is substituted with one or more R6;
- each R6 is independently H, D, halogen, CN, —OR5, —SR5, —S(═O)R4, —S(═O)2R4, —S(═O)2N(R5)2, —NR5S(═O)2R4, —C(═O)R4, —OC(═O)R4, —CO2R5, —OCO2R4, N(R5)2, —OC(═O)N(R5)2, —C(═O)N(R5)2, —NR5C(═O)R4, —NR5C(═O)OR4, substituted or unsubstituted C1-C6alkyl, substituted or unsubstituted C1-C6fluoroalkyl, substituted or unsubstituted C1-C6deuteroalkyl, substituted or unsubstituted C1-C6heteroalkyl, substituted or unsubstituted C3-C10cycloalkyl, substituted or unsubstituted C3-C10deuterocycloalkyl, substituted or unsubstituted C2-C10heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl;
- each R4 is independently a substituted or unsubstituted C1-C6alkyl, substituted or unsubstituted C1-C6fluoroalkyl, substituted or unsubstituted C1-C6deuteroalkyl, substituted or unsubstituted C3-C10cycloalkyl, substituted or unsubstituted C3-C10deuterocycloalkyl, substituted or unsubstituted C2-C10heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl;
- each R5 is independently H, substituted or unsubstituted C1-C6alkyl, substituted or unsubstituted C1-C6fluoroalkyl, substituted or unsubstituted C1-C6deuteroalkyl, substituted or unsubstituted C1-C6heteroalkyl, substituted or unsubstituted C3-C10cycloalkyl, substituted or unsubstituted C3-C10deuterocycloalkyl, substituted or unsubstituted C2-C10heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl;
- or two R5 groups attached to the same N atom are taken together with carbon atom to which they are attached to form a substituted or unsubstituted carbocycle or substituted or unsubstituted heterocycle;
- each R3 is independently H, D, halogen, —CN, —OH, —OC1-C6alkyl, —OC1-C6fluoroalkyl, —OC1-C6deuteroalkyl, C1-C6alkyl, C1-C6fluoroalkyl, C1-C6deuteroalkyl, or C1-C6heteroalkyl;
- m is 0, 1, or 2.
9 more elements
Dependencies are inferred from the claim text.